News

2016 Apr 19

Computer to clinic: Tool developed at Weill predicts drug success

A computational tool created by a graduate student in the lab of Olivier Elemento, Ph.D, has realized its first clinical application - less than a year after its development. Read more

2016 Apr 18

First-in-class antibody-drug conjugate shows promising preliminary results for metastatic platinum-resistant urothelial cancer

Scott Tagawa, M.D., M.S., discusses the results of a phase I/II trial into a promising new immunotherapy drug for bladder cancer. Read more

Photo of Drs. Rubin, Sboner, Beltran and Elemento

2016 Apr 17

Englander Institute joins international genomic medicine effort

Tumors sequenced at Weill Cornell Medicine/NewYork-Presbyterian could help further cancer research across the globe, as part of the International Cancer Genome Consortium Read more

2016 Apr 15

Panoply of new agents, complete remission rates mark ‘special day’ in myeloma

Ruben Niesvizky, M.D., discusses the “privilege” of caring for patients with myeloma in an era of therapeutic milestones. Read more

Silvia Formenti, M.D., is pioneering the use of radiation for immunotherapy in cancer

2016 Apr 15

The promise of combining radiotherapy and immunotherapy to treat cancer

Silvia Formenti, M.D., discusses her novel approach to immunotherapy using radiation treatment. Read more

Ekta Khurana, Ph.D., assistant professor of computational biology at the Meyer Cancer Center, Weill Cornell Medicine

2016 Apr 14

Cancer genomics: Hard-to-reach repairs

Ekta Khurana, Ph.D., comments on two studies about DNA repair mechanisms. Read more

Doctors at Meyer Cancer Center are enrolling cancer patients in immunotherapy trials

2016 Apr 13

Lymphoma researchers earn Top 10 Clinical Research Award

The lymphoma clinical research group has received a Clinical Research Forum award for its study demonstrating the efficacy of an innovative combination therapy for treating mantle cell lymphoma. Read more

2016 Apr 13

Unraveling how obesity fuels cancer

Andrew Dannenberg, M.D., discusses the effect of inflammation and aromatase expression on breast cancer risk. Read more

2016 Apr 11

A Pathway to Success: Studying signal transduction in cancer and other diseases

Lewis Cantley, Ph.D., discusses his career in science Read more

2016 Apr 08

Scientists push to expand survival rates for brain cancer patients

One size does not fit all for brain cancer treatment, says Howard Fine, M.D. Read more

2016 Apr 08

The transformation of oncology

We are living in a remarkable time for cancer research - let's take advantage of it, says Harold Varmus, M.D., Read more

Marcin Imielinski, M.D., Ph.D., computational biologist at Meyer Cancer Center, Weill Cornell Medicine

2016 Apr 08

A career in cancer research? Computational skills wanted

Marcin Imielinski, M.D., Ph.D., and Mark Rubin, M.D., discuss burgeoning career options in cancer research. Read more

2016 Apr 06

Cancer metastases: Are one and all the same?

Himisha Beltran, M.D., comments on a study on prostate cancer pathogenesis and metastasis. Read more

2016 Apr 06

Most cancer patients have overly optimistic view of their life expectancy

Most patients have an overly optimistic view of their life expectancy and that few patients base their estimate on communications with their healthcare providers, said Holly Prigerson, Ph.D. Read more

2016 Apr 04

How not to end cancer in our lifetimes

Dean Laurie Glimcher, M.D., discusses proposed rules governing the usage of human tissue in research. Read more

2016 Apr 04

When to treat patients with follicular lymphoma

John Leonard, M.D., talks to Targeted Oncology about treatment options for patients with follicular lymphoma. Read more

2016 Apr 01

Broccoli sheds light on RNA-modifying enzymes

The lab of Samie Jaffrey, M.D., Ph.D., has created Broccoli, a derivative of the Spinach fluorescent aptamer for assaying RNA-modifying enzymes. Read more

2016 Mar 31

Leading cancer scientist & entrepreneur on research in NY

Meyer director Lewis Cantley, Ph.D., discusses the research scene in New York City. Read more

2016 Mar 30

“Raw Potential” and three other takeaways from NY’s Life Science Disruptors

Lewis Cantley, Ph.D., discusses the biotech industry in New York City. Read more

2016 Mar 30

Researchers turn to canine clinical trials to advance cancer therapies

Kristy Richards, M.D., Ph.D., discusses the use of dogs to study canine and human cancer Read more

News

Computer to clinic: Tool developed at Weill predicts drug success

First-in-class antibody-drug conjugate shows promising preliminary results for metastatic platinum-resistant urothelial cancer

Englander Institute joins international genomic medicine effort

Panoply of new agents, complete remission rates mark ‘special day’ in myeloma

The promise of combining radiotherapy and immunotherapy to treat cancer

Cancer genomics: Hard-to-reach repairs

Lymphoma researchers earn Top 10 Clinical Research Award

Unraveling how obesity fuels cancer

A Pathway to Success: Studying signal transduction in cancer and other diseases

Scientists push to expand survival rates for brain cancer patients

The transformation of oncology

A career in cancer research? Computational skills wanted

Cancer metastases: Are one and all the same?

Most cancer patients have overly optimistic view of their life expectancy

How not to end cancer in our lifetimes

When to treat patients with follicular lymphoma

Broccoli sheds light on RNA-modifying enzymes

Leading cancer scientist & entrepreneur on research in NY

“Raw Potential” and three other takeaways from NY’s Life Science Disruptors

Researchers turn to canine clinical trials to advance cancer therapies

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters